Ashwagandha vs Vitamin D
Both are commonly discussed for immune health. Ashwagandha and Vitamin D both have moderate evidence — Ashwagandha edges ahead on research volume (20 vs 20 studies referenced).
Evidence last reviewed May 2026
Ashwagandha
Adaptogen
Vitamin D
Fat-Soluble Vitamin
Evidence
🟡Moderate Evidence
🟡Moderate Evidence
Research says
Research agrees
Partially supported
Expert mentions
356
3 recommend
245
3 recommend
Studies
20
referenced
20
referenced
Study dose
300–600mg
The majority of positive RCTs and the meta-analytic evidence supporting stress and anxiety reduction used standardized extracts (e.g., KSM-66 or Sensoril) in the range of 300–600 mg per day, administered as a single dose or split across two doses; higher withanolide standardization (≥5%) is associated with the studied effects.
—
Best timing
MorningEveningWith food
MorningWith food
Who recommends
Caution
Generally safe
Generally safe
Ashwagandha
Key findings
- ·Multiple RCTs and at least one meta-analysis support statistically significant reductions in perceived stress and anxiety with ashwagandha supplementation, making this the best-evidenced use case.
- ·Cortisol reduction has been reported across several placebo-controlled trials, suggesting a plausible biological mechanism underlying the stress-relief effects.
- ·Doses of 300–600 mg per day of standardized extract, consistent with those used in positive clinical trials, are referenced across the reviewed literature as the studied therapeutic range.
Evidence gaps
- ·Long-term safety data beyond 12 weeks is largely absent, leaving the risk profile for extended supplementation — including liver health — poorly characterized.
- ·Most trials use proprietary or specific extract formulations, making it unclear whether findings generalize to the wide variety of ashwagandha products available to consumers.
Vitamin D
Key findings
- ·A strong-quality meta-analysis supports combined calcium and vitamin D supplementation for reducing osteoporosis risk in postmenopausal women.
- ·A single moderate-quality RCT (D-Health trial) found limited evidence that vitamin D supplementation significantly reduces major cardiovascular events.
- ·One moderate-quality RCT found vitamin D supplementation was associated with higher testosterone levels in men, but this has not been sufficiently replicated.
Evidence gaps
- ·No studies in this review directly tested health outcomes at the specific serum vitamin D range of 60–80 ng/mL, leaving expert claims about optimal target levels unsupported by the current evidence base.
- ·The testosterone finding comes from a single moderate-quality RCT; additional well-powered replication trials are needed before this can be considered an established benefit.